Lab business > Distributorships & acquisitions

Abcam acquires live cells and lysates from EdiGene

26 July, 2019

Abcam has announced its acquisition of the entire live cell line and lysates portfolio of EdiGene, a Chinese company focused on developing genome editing technologies into novel therapeutics.

Agilent expands cell analysis portfolio with BioTek acquisition

19 July, 2019

Agilent Technologies has signed a definitive agreement to acquire the privately owned BioTek Instruments for $1.165 billion.

AXT to distribute stem cell solutions from StemBioSys

27 June, 2019

AXT has signed an agreement to distribute stem cell solutions from StemBioSys to researchers in Australia and New Zealand.

Thermo Fisher acquires HighChem but not Gatan

19 June, 2019

Thermo Fisher Scientific has completed its acquisition of HighChem but terminated the agreement under which it would have acquired Gatan.

AMS appointed distributor for Bronkhorst flow instrumentation

17 June, 2019

AMS Instrumentation & Calibration has been appointed the exclusive distributor for the Bronkhorst range of thermal, Coriolis and ultrasonic flowmeters and controllers for low flow rates of gases and liquids in Australia and its territories.

SCHOTT to acquire Australian microfluidic expert MINIFAB

13 June, 2019

SCHOTT, an international technology group in the areas of specialty glass and glass ceramics, has entered into a purchase agreement to acquire Australian microfluidic company MINIFAB.

AXT now offers TEM cameras from Direct Electron

21 May, 2019

Scientific equipment supplier AXT has announced the formation of a new relationship with US-based Direct Electron — a producer of next-generation detection cameras for transmission electron microscopes (TEM).

Thermo Fisher Scientific to acquire Brammer Bio for $1.7bn

28 March, 2019

Thermo Fisher Scientific has entered into a definitive agreement to acquire Brammer Bio, a leader in viral vector manufacturing for gene and cell therapies, for US$1.7 billion in cash.

AXT adds LIBS product line from ELEMISSION

31 January, 2019

AXT has signed an exclusive distribution agreement with ELEMISSION, a Canadian-based company that specialises in large-scale micro characterisation using continuous LIBS (laser-induced breakdown spectroscopy) scanning technology.

Arrow Pharmaceuticals and Apotex Australia propose merger

14 May, 2018

Arrow Pharmaceuticals and Apotex Australia have announced a proposed merger of their Australian and New Zealand generic pharmaceutical and OTC operations.

UNSW and France partner to strengthen scientific innovation

08 May, 2018

UNSW Vice-Chancellor Professor Ian Jacobs has signed agreements with France's largest government research organisation and the French Space Agency.

Scitech appointed authorised distributor for TissueGnostics

17 April, 2018

TissueGnostics is focused on integrated solutions for the scanning and analysis of microscopy slides, cytospins, smears and tissue microarrays.

Australia and US strike up STEM partnership

12 April, 2018

Science & Technology Australia and the American Association for the Advancement of Science have pledged to foster collaborations to enhance the role of STEM on the global stage.

Cannabis-focused biotech Zelda expands partnership with Curtin

07 March, 2018

Zelda Therapeutics, an Australian-listed biotech focused on medical cannabis, has expanded its pancreatic cancer research collaboration agreement with Curtin University.

Merck acquires Aus biotech Viralytics

22 February, 2018

Merck has acquired Australian listed cancer research firm Viralytics in a $502 million deal.

  • All content Copyright © 2019 Westwick-Farrow Pty Ltd